
Search Clinical Trials
| Sponsor Condition of Interest |
|---|
|
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
University of Colorado, Denver
Turner Syndrome
INSIGHTS is a registry research study that collects key information on medical history
for girls and women with Turner syndrome and the clinical care they receive. This
includes genetic tests, imaging, medications, and more for hundreds of patients seen at a
number of clinics across the US. In addi1 expand
INSIGHTS is a registry research study that collects key information on medical history for girls and women with Turner syndrome and the clinical care they receive. This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. In addition to learning a lot about the current state of health for individuals with TS, INSIGHTS serves as an infrastructure to conduct future studies are meaningful to patients and their families. Type: Observational [Patient Registry] Start Date: May 2020 |
|
Systemic Biomarkers of Brain Injury From Hyperammonemia
Children's National Research Institute
Urea Cycle Disorder
Organic Acidemia
Maple Syrup Urine Disease
Glutaric Acidemia I
Fatty Acid Oxidation Disorder
Ammonia is a waste product of protein and amino acid catabolism and is also a potent
neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema
and vascular compromise leading to intellectual and developmental disabilities. The
following aims are proposed:
Aim 1 of th1 expand
Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema and vascular compromise leading to intellectual and developmental disabilities. The following aims are proposed: Aim 1 of this study will be to determine the chronology of biomarkers of brain injury in response to a hyperammonemic (HA) brain insult in patients with an inherited hyperammonemic disorder. Aim 2 will be to determine if S100B, NSE, and UCHL1 are altered in patients with two other inborn errors of metabolism, Maple Syrup Urine Disease (MSUD) and Glutaric Acidemia (GA1). Type: Observational Start Date: Jul 2020 |